2026
01 Participated in AEEDC DUBAI (01.19 - 01.21)
01 Participated in AEEDC DUBAI (01.19 - 01.21)
03 Participated in IDS Cologne (03.25 - 03.29)
02 Participated in AEEDC DUBAI (02.04 - 02.06)
02 Participated in AEEDC DUBAI (02.06 - 02.08)
03 Participated in IDS Cologne (03.14 - 03.18)
02 Participated in AEEDC DUBAI (02.07 - 02.09)
02 Participated in AEEDC DUBAI (02.01 - 02.03)
07 Acquired CRUXVIEW FDA certification
05 Acquired NMPA China certification
11 Acquired PMDA Japan certification
08 Acquired CRUXVIEW CE certification
02 Participated in AEEDC DUBAI
12 Participated in New York Dental Meeting (12.01 - 12.04)
06 Participated in IDEA (06.20 - 06.22)
06 Received GMP approval
05 Participated in HKTDC (05.14 - 05.16)
05 Acquired CE Europe certification and ISO 13485 approval
03 Participated in IDS Cologne (03.12 - 03.16)
02 Participated in AEEDC DUBAI (02.05 - 02.07)
02 Secured investment from PointNix, increased capital, and acquired FDA certification
11 Participated in New York Dental Meeting (11.25 - 11.28)
09 Selected for TIPS and began sales of CRUXCAN CRX-1000
08 Designated as a promising export company
07 Acquired KFDA and KGMP certifications, medical device manufacturing license, research institute company registration, secured Korea Credit Guarantee Fund investment, and increased capital
06 Secured investment from ETRI Holdings and increased capital
01 Certified as a management innovation-type SME
12 Selected for industry-academia-research cooperative technology development project
11 Selected for technology transfer commercialization project
09 Recognized as a corporate research institute by KOITA
05 Relocated headquarters from Taplip-dong to Yongsan-dong
03 Recognized as a venture company
12 Increased capital and selected for purchase-conditioned new technology development project
09 Recognized as a dedicated R&D department by KOITA
07 Cruxell Co., Ltd. established